TIDM43CT TIDM0RN3
RNS Number : 6276M
Morgan Stanley
09 January 2019
FORM 8.5 (EPT/NON-RI)
PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY AN
EXEMPT PRINCIPAL TRADER WITHOUT RECOGNISED INTERMEDIARY ("RI")
STATUS (OR WHERE RI STATUS IS NOT APPLICABLE)
Rule 8.5 of the Takeover Code (the "Code")
1. KEY INFORMATION
(a) Name of exempt principal trader: Morgan Stanley MUFG Securities Co., Ltd.
(b) Name of offeror/offeree in relation to whose relevant securities this Takeda Pharmaceutical Company Limited
form relates:
Use a separate form for each offeror/offeree
-----------------------------------------
(c) Name of the party to the offer with which exempt principal trader is Shire plc
connected:
-----------------------------------------
(d) Date position held/dealing undertaken 08 JANUARY 2019
For an opening position disclosure, state the latest practicable date
prior to the disclosure
-----------------------------------------
(e) In addition to the company in 1(b) above, is the exempt principal Yes - Shire plc
trader making disclosures
in respect of any other party to this offer?
If it is a cash offer or possible cash offer, state "N/A"
-----------------------------------------
2. POSITIONS OF THE EXEMPT PRINCIPAL TRADER
If there are positions or rights to subscribe to disclose in
more than one class of relevant securities of the offeror or
offeree named in 1(b), copy table 2(a) or (b) (as appropriate) for
each additional class of relevant security.
(a) Interests and short positions in the relevant securities of
the offeror or offeree to which the disclosure relates following
the dealing (if any)
Class of relevant security: Ordinary
Interests Short positions
---------------- -----------------
Number % Number %
---------- ---- ----------- ----
(1) Relevant securities owned
and/or controlled: 4,423,915 0.56 35,544,949 4.53
---------- ---- ----------- ----
(2) Cash-settled derivatives: 34,686,223 4.42 3,545,959 0.45
---------- ---- ----------- ----
(3) Stock-settled derivatives
(including options) and agreements
to purchase/sell: 315,000 0.04 315,000 0.04
---------- ---- ----------- ----
TOTAL: 39,425,138 5.03 39,405,908 5.02
---------- ---- ----------- ----
All interests and all short positions should be disclosed.
Details of any open stock-settled derivative positions
(including traded options), or agreements to purchase or sell
relevant securities, should be given on a Supplemental Form 8 (Open
Positions).
(b) Rights to subscribe for new securities (including directors' and other employee options)
Class of relevant security in N/A
relation to which subscription
right exists:
Details, including nature of N/A
the rights concerned and relevant
percentages:
----
3. DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER
Where there have been dealings in more than one class of
relevant securities of the offeror or offeree named in 1(b), copy
table 3(a), (b), (c) or (d) (as appropriate) for each additional
class of relevant security dealt in.
The currency of all prices and other monetary amounts should be
stated.
(a) Purchases and sales
Class of Purchases/ Total number Highest price Lowest price
relevant sales of securities per unit paid/received per unit paid/received
security
Ordinary PURCHASES 3,061,136 4,150.3600 3,972.2495
JPY JPY
----------- --------------- ------------------------ ------------------------
Ordinary SALES 3,014,772 4,150.3600 3,972.2495
JPY JPY
----------- --------------- ------------------------ ------------------------
(b) Cash-settled derivative transactions
Class of Product description Nature of dealing Number of reference Price per
relevant e.g. CFD e.g. opening/closing securities unit
security a long/short position,
increasing/reducing
a long/short position
Ordinary CFD 4085.0000
SHORT 14500 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4064.2296
LONG 27000 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4096.2152
SHORT 68300 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4085.0000
LONG 7000 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 3977.1927
SHORT 24900 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4067.0366
LONG 32700 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4046.0000
SHORT 6500 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4061.2015
LONG 39200 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4068.1666
SHORT 1800 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4082.4074
SHORT 5400 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4068.4210
LONG 3800 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4043.0000
LONG 200 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4068.1086
LONG 300 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4068.1086
LONG 4300 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4056.0000
SHORT 300 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4057.8461
SHORT 9100 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4061.5357
LONG 8400 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4037.9166
SHORT 2400 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 3995.0000
LONG 1200 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4056.1075
LONG 111196 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4010.1029
SHORT 155697 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4064.7501
LONG 65800 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4043.0780
LONG 601408 JPY
-------------------- ------------------------ -------------------- ----------
Ordinary CFD 4062.0253
SHORT 703308 JPY
-------------------- ------------------------ -------------------- ----------
(c) Stock-settled derivative transactions (including options)
(i) Writing, selling, purchasing or varying
Class Product Writing, Number Exercise Type Expiry Option
of description purchasing, of securities price e.g. American, date money paid/
relevant e.g. call selling, to which per unit European received
security option varying option etc. per unit
etc. relates
N/A N/A N/A N/A N/A N/A N/A N/A
------------- ------------- --------------- ---------- ---------------- ------- -------------
(ii) Exercise
Class of Product description Exercising/ Number of securities Exercise price
relevant e.g. call option exercised per unit
security against
N/A N/A N/A N/A N/A
-------------------- ------------ --------------------- ---------------
(d) Other dealings (including subscribing for new securities)
Class of relevant Nature of dealing Details Price per unit
security e.g. subscription, (if applicable)
conversion
N/A N/A N/A N/A
-------------------- -------- -----------------
4. OTHER INFORMATION
(a) Indemnity and other dealing arrangements
Details of any indemnity or option arrangement, or any agreement or understanding,
formal or informal, relating to relevant securities which may be an inducement to deal
or refrain from dealing entered into by the exempt principal trader making the
disclosure and any party to the offer or any person acting in concert with a party to the
offer:
Irrevocable commitments and letters of intent should not be included. If there are no such
agreements, arrangements or understandings, state "none"
NONE
(b) Agreements, arrangements or understandings relating to options or derivatives
Details of any agreement, arrangement or understanding, formal or informal, between
the exempt principal trader making the disclosure and any other person relating to:
(i) the voting rights of any relevant securities under any option; or
(ii) the voting rights or future acquisition or disposal of any relevant securities to which
any derivative is referenced:
If there are no such agreements, arrangements or understandings, state "none"
NONE
(c) Attachments
Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 09 JANUARY 2019
Contact name: Craig Horsley
------------------
Telephone number: +44(141) 245 7736
------------------
Public disclosures under Rule 8 of the Code must be made to a
Regulatory Information Service.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk.
SUPPLEMENTAL FORM 8 (OPEN POSITIONS)
DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION)
POSITIONS,
AGREEMENTS TO PURCHASE OR SELL ETC.
Note 5(i) on Rule 8 of the Takeover Code (the "Code")
1. KEY INFORMATION
Full name of person making disclosure: Morgan Stanley MUFG Securities Co., Ltd.
Name of offeror/offeree in relation to whose relevant securities the Takeda Pharmaceutical Company Limited
disclosure relates:
-----------------------------------------
2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)
Class of Product Written Number of Exercise Type Expiry
relevant description or purchased securities price e.g. American, date
security e.g. call to which per unit European
option option or etc
derivative
relates
Ordinary PUT PURCHASED 125,000 4507.0000 European 13/12/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary CALL PURCHASED 125,000 4507.0000 European 13/12/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary PUT PURCHASED 60,000 4596.0000 European 14/06/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary CALL PURCHASED 60,000 4596.0000 European 14/06/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary PUT PURCHASED 65,000 4414.0000 European 14/06/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary CALL PURCHASED 65,000 4414.0000 European 14/06/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary PUT PURCHASED 65,000 4414.0000 European 13/12/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
Ordinary CALL PURCHASED 65,000 4414.0000 European 13/12/2019
JPY
------------ ------------- ----------- --------- --------------- ----------
3. AGREEMENTS TO PURCHASE OR SELL ETC.
Full details should be given so that the nature of the interest
or position can be fully understood:
It is not necessary to provide details on a Supplemental Form
(Open Positions) with regard to cash-settled derivatives.
The currency of all prices and other monetary amounts should be
stated.
The Panel's Market Surveillance Unit is available for
consultation in relation to the Code's disclosure requirements on
+44 (0)20 7638 0129.
The Code can be viewed on the Panel's website at
www.thetakeoverpanel.org.uk
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
FEOEANFNELPNEEF
(END) Dow Jones Newswires
January 09, 2019 04:49 ET (09:49 GMT)
Takeda Pharmaceutical (LSE:0RN3)
Historical Stock Chart
From Jun 2024 to Jul 2024
Takeda Pharmaceutical (LSE:0RN3)
Historical Stock Chart
From Jul 2023 to Jul 2024